Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Curanex Pharmaceuticals Inc is a developmental stage pharmaceutical company. The Company is engaged in discovering, developing, and commercializing botanical drugs to treat patients suffering from inflammatory diseases and to develop therapies that offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections. Its lead candidate, Phyto-N, is a botanical extract from a single plant with anti-inflammatory properties that act via multiple targets and mechanisms. Its drug development pipelines encompass six various therapeutic areas: ulcerative colitis, atopic dermatitis, COVID-19, diabetes, NAFLD, and gout. Phyto-N is being developed as an orally administered alternative for patients with moderate to severe ulcerative colitis, aiming to address limitations of current treatments. The Company's two botanical drugs include Veregen (sinecatechins) and Fulyzaq/Mytesi (crofelemer).
Find out what a historical investment in Curanex Pharmaceuticals would be worth today using our CURX stock calculator.
Buying CURX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Curanex Pharmaceuticals in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CURX
What is the ticker symbol of Curanex Pharmaceuticals?
The ticker symbol for Curanex Pharmaceuticals is CURX.
How much is one share of CURX?
One share of CURX is valued at $4.44 as of 20 November 2026.
What is the market capitalisation of Curanex Pharmaceuticals CURX?
As of 20 November 2026 Curanex Pharmaceuticals has a market cap of $7.37M.
What is the 52-week high for Curanex Pharmaceuticals stock?
The Curanex Pharmaceuticals 52-week high stock price is $13.33.
What is the 52-week low for Curanex Pharmaceuticals stock?
The Curanex Pharmaceuticals 52-week low stock price is $3.58.
Can I buy CURX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CURX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CURX on Stake
Buy CURX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CURX from only US$10 with fractional shares